6FC8

CHK1 KINASE IN COMPLEX WITH COMPOUND 13

6FC8 の概要

• エントリーDOI: 10.2210/pdb6fc8/pdb
• 分子名称: Serine/threonine-protein kinase Chk1, SULFATE ION, 2-(3-fluorophenyl)-4-[[(3~{S})-piperidin-3-yl]amino]thieno[3,2-c]pyridine-7-carboxamide, ... (4 entities in total)
• 機能のキーワード: inhibitor, complex, chk1, kinase, transferase
• 由来する生物種: Homo sapiens (Human)
• 細胞内の位置: Nucleus: O14757
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 32307.24

構造登録者

Read, J.A.,Breed, J. (登録日: 2017-12-20, 公開日: 2018-01-17, 最終更新日: 2024-05-08)

主引用文献

Yang, B.,Vasbinder, M.M.,Hird, A.W.,Su, Q.,Wang, H.,Yu, Y.,Toader, D.,Lyne, P.D.,Read, J.A.,Breed, J.,Ioannidis, S.,Deng, C.,Grondine, M.,DeGrace, N.,Whitston, D.,Brassil, P.,Janetka, J.W.
Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors.
J. Med. Chem., 61:1061-1073, 2018

PubMed Abstract: Checkpoint kinase 1 (CHK1) inhibitors are potential cancer therapeutics that can be utilized for enhancing the efficacy of DNA damaging agents. Multiple small molecule CHK1 inhibitors from different chemical scaffolds have been developed and evaluated in clinical trials in combination with chemotherapeutics and radiation treatment. Scaffold morphing of thiophene carboxamide ureas (TCUs), such as AZD7762 (1) and a related series of triazoloquinolines (TZQs), led to the identification of fused-ring bicyclic CHK1 inhibitors, 7-carboxamide thienopyridines (7-CTPs), and 7-carboxamide indoles. X-ray crystal structures reveal a key intramolecular noncovalent sulfur-oxygen interaction in aligning the hinge-binding carboxamide group to the thienopyridine core in a coplanar fashion. An intramolecular hydrogen bond to an indole NH was also effective in locking the carboxamide in the preferred bound conformation to CHK1. Optimization on the 7-CTP series resulted in the identification of lead compound 44, which displayed respectable drug-like properties and good in vitro and in vivo potency.

PubMed: 29301085
DOI: 10.1021/acs.jmedchem.7b01490

実験手法

X-RAY DIFFRACTION (1.61 Å)